Clinical Trial Update: Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating sodium thiosulfate to prevent cisplatin-induced hearing loss in young patients with various pediatric cancers; study completed with res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumor
• Central Nervous System Tumor
• Childhood Germ Cell Tumor
• Extragonadal Germ Cell Tumor
• Liver Cancer
• Neuroblastoma
• Ototoxicity

Drugs mentioned

• Sodium thiosulfate (sodium thiosulfate)

Snippet

Sponsor: Children's Oncology Group | Conditions: Brain Tumor, Central Nervous System Tumor | Phase 3 | Status: COMPLETED | Results posted: 2017-06-01